ArticleCancer immunology, immunotherapy : CII2023

Clinical roles of soluble PD-1 and PD-L1 in plasma of NSCLC patients treated with immune checkpoint inhibitors.

Hidetomo Himuro et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.